Trial Profile
Confirmatory Study of OPC-12759 Ophthalmic Solution in Patients With Dry Eye
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Dec 2021
Price :
$35
*
At a glance
- Drugs Rebamipide (Primary)
- Indications Dry eyes
- Focus Registrational; Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 24 Apr 2015 New trial record